Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	inhibitory MHC class I receptor activity	LILRA1 LILRB3 LILRA3 LILRB1 LILRB4	3.56e-09	12	110	5	GO:0032396
GeneOntologyMolecularFunction	MHC class I receptor activity	LILRA1 LILRB3 LILRA3 LILRB1 LILRB4	3.75e-08	18	110	5	GO:0032393
GeneOntologyMolecularFunction	IgM binding	LILRA1 LILRB3 LILRB1	2.60e-05	11	110	3	GO:0001791
GeneOntologyMolecularFunction	coreceptor activity	LILRA1 LILRB3 LILRB1 LRP5 IL6ST	4.83e-05	72	110	5	GO:0015026
GeneOntologyMolecularFunction	SUMO ligase activity	RGPD4 RGPD1 RGPD3	1.73e-04	20	110	3	GO:0061665
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRA1 LILRB1	2.97e-04	5	110	2	GO:0030107
GeneOntologyMolecularFunction	immune receptor activity	LILRA1 LILRB3 LILRA3 LILRB1 IL6ST LILRB4	3.06e-04	165	110	6	GO:0140375
GeneOntologyMolecularFunction	HLA-B specific inhibitory MHC class I receptor activity	LILRA1 LILRB1	4.45e-04	6	110	2	GO:0030109
GeneOntologyMolecularFunction	MHC class Ib protein complex binding	LILRA1 LILRB1	6.20e-04	7	110	2	GO:0023025
GeneOntologyMolecularFunction	alpha-actinin binding	SYNPO2 PDLIM7 ALMS1	6.53e-04	31	110	3	GO:0051393
GeneOntologyMolecularFunction	cytoskeletal protein binding	SYNPO2 MAP7D3 PSG3 KIF26B PDLIM7 COBLL1 SPIRE1 SYNPO SORBS1 ALMS1 TTLL6 MACO1 TTLL4 DLG1 MTUS2	1.01e-03	1099	110	15	GO:0008092
GeneOntologyMolecularFunction	immunoglobulin binding	LILRA1 LILRB3 LILRB1	1.02e-03	36	110	3	GO:0019865
GeneOntologyMolecularFunction	SUMO transferase activity	RGPD4 RGPD1 RGPD3	1.02e-03	36	110	3	GO:0019789
GeneOntologyMolecularFunction	protein-glutamic acid ligase activity	TTLL6 TTLL4	1.31e-03	10	110	2	GO:0070739
GeneOntologyMolecularFunction	tubulin-glutamic acid ligase activity	TTLL6 TTLL4	1.31e-03	10	110	2	GO:0070740
GeneOntologyMolecularFunction	structural constituent of synapse	DLGAP1 PCLO DLG1	1.60e-03	42	110	3	GO:0098918
GeneOntologyMolecularFunction	structural constituent of postsynaptic density	DLGAP1 DLG1	1.60e-03	11	110	2	GO:0098919
GeneOntologyMolecularFunction	actinin binding	SYNPO2 PDLIM7 ALMS1	1.71e-03	43	110	3	GO:0042805
GeneOntologyMolecularFunction	structural constituent of postsynaptic specialization	DLGAP1 DLG1	2.25e-03	13	110	2	GO:0098879
GeneOntologyMolecularFunction	amyloid-beta binding	CACNA1B LILRA1 LILRB3 LILRB1	2.45e-03	102	110	4	GO:0001540
GeneOntologyMolecularFunction	tubulin binding	MAP7D3 KIF26B SPIRE1 ALMS1 TTLL6 MACO1 TTLL4 MTUS2	2.55e-03	428	110	8	GO:0015631
GeneOntologyMolecularFunction	peptidyl-prolyl cis-trans isomerase activity	RGPD4 RGPD1 RGPD3	2.64e-03	50	110	3	GO:0003755
GeneOntologyMolecularFunction	muscle alpha-actinin binding	SYNPO2 PDLIM7	3.01e-03	15	110	2	GO:0051371
GeneOntologyMolecularFunction	cis-trans isomerase activity	RGPD4 RGPD1 RGPD3	3.12e-03	53	110	3	GO:0016859
GeneOntologyMolecularFunction	MHC class Ib protein binding	LILRA1 LILRB1	3.43e-03	16	110	2	GO:0023029
GeneOntologyMolecularFunction	phosphatase binding	CACNA1B LILRA1 PSG3 LILRB1 DLG1 LILRB4	3.44e-03	264	110	6	GO:0019902
GeneOntologyBiologicalProcess	positive regulation of glucokinase activity	RGPD4 RGPD1 RGPD3	1.24e-05	9	111	3	GO:0033133
GeneOntologyBiologicalProcess	negative regulation of osteoclast differentiation	LILRA1 LILRB3 PSG3 LILRB1 LILRB4	1.64e-05	59	111	5	GO:0045671
GeneOntologyBiologicalProcess	positive regulation of hexokinase activity	RGPD4 RGPD1 RGPD3	1.77e-05	10	111	3	GO:1903301
GeneOntologyBiologicalProcess	interleukin-10-mediated signaling pathway	LILRA1 LILRA3 LILRB1	2.43e-05	11	111	3	GO:0140105
GeneOntologyBiologicalProcess	osteoclast differentiation	LILRA1 LILRB3 PSG3 LRRK1 LILRB1 SBNO2 LILRB4	2.77e-05	162	111	7	GO:0030316
GeneOntologyBiologicalProcess	regulation of glucokinase activity	RGPD4 RGPD1 RGPD3	4.17e-05	13	111	3	GO:0033131
GeneOntologyBiologicalProcess	regulation of hexokinase activity	RGPD4 RGPD1 RGPD3	5.29e-05	14	111	3	GO:1903299
GeneOntologyBiologicalProcess	positive regulation of long-term synaptic depression	LILRA1 LILRB1 KCNB1	5.29e-05	14	111	3	GO:1900454
GeneOntologyBiologicalProcess	negative regulation of myeloid leukocyte differentiation	LILRA1 LILRB3 PSG3 LILRB1 LILRB4	9.60e-05	85	111	5	GO:0002762
GeneOntologyBiologicalProcess	epithelium development	WHRN PSG3 TNC KIF26B PODXL CNMD SALL4 CHD7 RREB1 ALMS1 BTBD7 KLF5 ERRFI1 KDM2B LRP5 DLG1 C3 HYDIN CUX1 IL6ST	1.02e-04	1469	111	20	GO:0060429
GeneOntologyBiologicalProcess	NLS-bearing protein import into nucleus	RGPD4 RGPD1 RGPD3	1.62e-04	20	111	3	GO:0006607
GeneOntologyCellularComponent	cytoplasmic periphery of the nuclear pore complex	RGPD4 RGPD1 RGPD3	8.22e-06	8	112	3	GO:1990723
GeneOntologyCellularComponent	Fc-epsilon receptor I complex	LILRA1 LILRB3 LILRB1	1.23e-05	9	112	3	GO:0032998
GeneOntologyCellularComponent	nuclear pore cytoplasmic filaments	RGPD4 RGPD1 RGPD3	1.75e-05	10	112	3	GO:0044614
GeneOntologyCellularComponent	Fc receptor complex	LILRA1 LILRB3 LILRB1	3.18e-05	12	112	3	GO:0032997
GeneOntologyCellularComponent	annulate lamellae	RGPD4 RGPD1 RGPD3	5.22e-05	14	112	3	GO:0005642
GeneOntologyCellularComponent	nuclear pore nuclear basket	RGPD4 RGPD1 RGPD3	1.15e-04	18	112	3	GO:0044615
GeneOntologyCellularComponent	nuclear inclusion body	RGPD4 RGPD1 RGPD3	1.60e-04	20	112	3	GO:0042405
GeneOntologyCellularComponent	SUMO ligase complex	RGPD4 RGPD1 RGPD3	1.86e-04	21	112	3	GO:0106068
GeneOntologyCellularComponent	nuclear pore	RGPD4 RGPD1 NUP214 RGPD3 NPAP1	2.12e-04	101	112	5	GO:0005643
GeneOntologyCellularComponent	inclusion body	RGPD4 RGPD1 RGPD3 TRIM37	1.40e-03	90	112	4	GO:0016234
GeneOntologyCellularComponent	perisynaptic extracellular matrix	TNC NCAN	1.52e-03	11	112	2	GO:0098966
HumanPheno	Abnormal number of teeth	CACNA1B ADAMTS3 COBLL1 CHD7 ALMS1 KCNB1 DLG1 PAX9 TRIM37 VPS13B CUX1 IL6ST	1.74e-05	421	36	12	HP:0006483
HumanPheno	Tooth agenesis	CACNA1B ADAMTS3 COBLL1 CHD7 ALMS1 KCNB1 DLG1 PAX9 TRIM37 VPS13B CUX1	2.45e-05	363	36	11	HP:0009804
HumanPheno	Clavicular sclerosis	LRRK1 LRP5	4.86e-05	2	36	2	HP:0100923
MousePheno	abnormal tumor latency	RGPD4 RGPD1 RGPD3 TREM1 DCLRE1A	3.62e-06	34	98	5	MP:0010307
Domain	A1B_glyco/leuk_Ig-like_rcpt	LILRA1 LILRA3 LILRA6	3.82e-06	6	109	3	IPR016332
Domain	GCC2_Rab_bind	RGPD4 RGPD1 RGPD3	6.65e-06	7	109	3	IPR032023
Domain	Rab_bind	RGPD4 RGPD1 RGPD3	6.65e-06	7	109	3	PF16704
Domain	-	RGPD4 RGPD1 RGPD3	2.25e-05	10	109	3	1.10.220.60
Domain	PDZ	WHRN SYNPO2 IL16 FRMPD4 PDLIM7 PCLO DLG1	2.94e-05	151	109	7	PS50106
Domain	PDZ	WHRN SYNPO2 IL16 FRMPD4 PDLIM7 PCLO DLG1	3.07e-05	152	109	7	IPR001478
Domain	Grip	RGPD4 RGPD1 RGPD3	3.08e-05	11	109	3	SM00755
Domain	GRIP	RGPD4 RGPD1 RGPD3	3.08e-05	11	109	3	PF01465
Domain	Aquaporin_12	AQP12A AQP12B	3.37e-05	2	109	2	IPR023265
Domain	Ran_BP1	RGPD4 RGPD1 RGPD3	4.09e-05	12	109	3	PF00638
Domain	GRIP_dom	RGPD4 RGPD1 RGPD3	4.09e-05	12	109	3	IPR000237
Domain	GRIP	RGPD4 RGPD1 RGPD3	4.09e-05	12	109	3	PS50913
Domain	RANBD1	RGPD4 RGPD1 RGPD3	4.09e-05	12	109	3	PS50196
Domain	RanBD	RGPD4 RGPD1 RGPD3	5.30e-05	13	109	3	SM00160
Domain	Ran_bind_dom	RGPD4 RGPD1 RGPD3	5.30e-05	13	109	3	IPR000156
Domain	Ig_2	LILRA1 LILRA3 PSG3 LILRB1 LILRB4	6.76e-05	73	109	5	PF13895
Domain	Aquaporin_11/12	AQP12A AQP12B	1.01e-04	3	109	2	IPR016697
Domain	ig	LILRA1 LILRB3 LILRA3 PSG3 LILRA6 LILRB1 LILRB4	1.25e-04	190	109	7	PF00047
Domain	Immunoglobulin	LILRA1 LILRB3 LILRA3 PSG3 LILRA6 LILRB1 LILRB4	1.25e-04	190	109	7	IPR013151
Domain	PDZ	WHRN SYNPO2 IL16 FRMPD4 PDLIM7 DLG1	1.78e-04	141	109	6	PF00595
Domain	MAP7_fam	MAP7D3 MAP7D2	2.01e-04	4	109	2	IPR008604
Domain	MAP7	MAP7D3 MAP7D2	2.01e-04	4	109	2	PF05672
Domain	PDZ	WHRN SYNPO2 IL16 FRMPD4 PDLIM7 DLG1	2.32e-04	148	109	6	SM00228
Domain	Ig-like_fold	LILRA1 LILRB3 LILRA3 TRIM42 PSG3 TNC LILRA6 CMYA5 LILRB1 NCAN TREM1 IL6ST LILRB4	2.39e-04	706	109	13	IPR013783
Domain	-	WHRN SYNPO2 IL16 FRMPD4 PDLIM7 DLG1	2.49e-04	150	109	6	2.30.42.10
Domain	IG	LILRA1 LILRB3 LILRA3 PSG3 LILRA6 LILRB1 NCAN TREM1 LILRB4	8.06e-04	421	109	9	SM00409
Domain	Ig_sub	LILRA1 LILRB3 LILRA3 PSG3 LILRA6 LILRB1 NCAN TREM1 LILRB4	8.06e-04	421	109	9	IPR003599
Domain	-	TMEM131 HYDIN	9.24e-04	8	109	2	2.60.40.360
Domain	PapD-like	TMEM131 HYDIN	1.18e-03	9	109	2	IPR008962
Domain	SH3_2	SORBS1 ITSN2 DLG1 MCF2L	1.61e-03	86	109	4	IPR011511
Domain	SH3_2	SORBS1 ITSN2 DLG1 MCF2L	1.61e-03	86	109	4	PF07653
Domain	-	LILRA1 LILRA3 TRIM42 PSG3 TNC CMYA5 LILRB1 NCAN TREM1 IL6ST LILRB4	1.70e-03	663	109	11	2.60.40.10
Domain	IG_LIKE	LILRA1 LILRB3 LILRA3 PSG3 LILRA6 LILRB1 NCAN TREM1 LILRB4	2.33e-03	491	109	9	PS50835
Domain	TTL	TTLL6 TTLL4	2.52e-03	13	109	2	PS51221
Domain	TTL/TTLL_fam	TTLL6 TTLL4	2.52e-03	13	109	2	IPR004344
Domain	TTL	TTLL6 TTLL4	2.52e-03	13	109	2	PF03133
Domain	Ig-like_dom	LILRA1 LILRB3 LILRA3 PSG3 LILRA6 LILRB1 NCAN TREM1 LILRB4	2.74e-03	503	109	9	IPR007110
Domain	MIP	AQP12A AQP12B	2.93e-03	14	109	2	PS00221
Domain	MIP	AQP12A AQP12B	2.93e-03	14	109	2	PF00230
Domain	MIP	AQP12A AQP12B	3.37e-03	15	109	2	IPR000425
Domain	-	AQP12A AQP12B	3.37e-03	15	109	2	1.20.1080.10
Domain	Aquaporin-like	AQP12A AQP12B	3.37e-03	15	109	2	IPR023271
Domain	PH_dom-like	RGPD4 FRMPD4 RGPD1 RGPD3 ITSN2 PLD2 MCF2L PLEKHO1	3.51e-03	426	109	8	IPR011993
Domain	TF_T-box	TBX10 MGA	4.33e-03	17	109	2	IPR001699
Domain	TBOX	TBX10 MGA	4.33e-03	17	109	2	SM00425
Domain	TF_T-box_CS	TBX10 MGA	4.33e-03	17	109	2	IPR018186
Domain	-	TBX10 MGA	4.33e-03	17	109	2	2.60.40.820
Domain	TBOX_3	TBX10 MGA	4.33e-03	17	109	2	PS50252
Domain	T-box	TBX10 MGA	4.33e-03	17	109	2	PF00907
Domain	TBOX_1	TBX10 MGA	4.33e-03	17	109	2	PS01283
Domain	TBOX_2	TBX10 MGA	4.33e-03	17	109	2	PS01264
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	LILRA1 LILRB3 LILRA3 LILRA6 LILRB1 TREM1 C3 LILRB4	1.19e-05	190	80	8	M8240
Pathway	REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY	RGPD4 RGPD1 NUP214 RGPD3	7.52e-05	40	80	4	MM14945
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS	RGPD4 RGPD1 NUP214 RGPD3	8.30e-05	41	80	4	MM15200
Pathway	REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS	RGPD4 RGPD1 NUP214 RGPD3	9.14e-05	42	80	4	MM15039
Pathway	REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA	RGPD4 RGPD1 NUP214 RGPD3	1.00e-04	43	80	4	MM14609
Pathway	BIOCARTA_RANBP2_PATHWAY	RGPD4 RGPD1 RGPD3	1.35e-04	18	80	3	MM1549
Pathway	REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS	RGPD4 RGPD1 NUP214 RGPD3	1.42e-04	47	80	4	MM14939
Pathway	REACTOME_GENE_SILENCING_BY_RNA	RGPD4 RGPD1 NUP214 RGPD3	1.68e-04	49	80	4	MM14837
Pathway	REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS	RGPD4 RGPD1 NUP214 RGPD3	1.82e-04	50	80	4	MM14610
Pathway	REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS	RGPD4 RGPD1 NUP214 RGPD3	1.96e-04	51	80	4	MM15151
Pathway	REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN	RGPD4 RGPD1 NUP214 RGPD3	2.63e-04	55	80	4	MM14917
Pathway	REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS	RGPD4 RGPD1 NUP214 RGPD3	3.23e-04	58	80	4	MM15149
Pathway	REACTOME_SNRNP_ASSEMBLY	RGPD4 RGPD1 NUP214 RGPD3	3.23e-04	58	80	4	MM14736
Pathway	REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS	RGPD4 RGPD1 NUP214 RGPD3	5.01e-04	65	80	4	MM15147
Pathway	REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE	RGPD4 RGPD1 NUP214 RGPD3	7.78e-04	73	80	4	MM14948
Pubmed	A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules.	LILRA1 LILRB3 LILRA3 LILRB1 LILRB4	1.92e-11	8	114	5	9548455
Pubmed	Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways.	LILRB3 LILRA3 LILRB1 LILRB4	1.63e-09	6	114	4	9079806
Pubmed	Differential expression of leukocyte immunoglobulin-like receptors on cord-blood-derived human mast cell progenitors and mature mast cells.	LILRA1 LILRB3 LILRB1 LILRB4	3.80e-09	7	114	4	17998301
Pubmed	Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.	LILRA1 LILRB3 LILRB1 LILRB4	3.80e-09	7	114	4	19658091
Pubmed	Comprehensive identification of phosphorylation sites in postsynaptic density preparations.	RGPD4 CACNA1B TNC PCLO RGPD1 SYNPO SORBS1 KCNB1 RGPD3 SRRM2	5.12e-09	231	114	10	16452087
Pubmed	A human MAP kinase interactome.	DLGAP1 SYNPO2 KIF26B COBLL1 SYNPO SORBS1 NUP214 MIDEAS ATF6 ITSN2 ERRFI1 MGA CUX1	7.95e-09	486	114	13	20936779
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	WHRN FRMPD4 KIAA1549 SORBS1 BAHD1 ALMS1 ITSN2 HACE1	1.21e-08	130	114	8	12421765
Pubmed	Inhibitory immunoglobulin-like receptors LILRB and PIR-B negatively regulate osteoclast development.	LILRA1 LILRB3 LILRB1 LILRB4	2.26e-08	10	114	4	18802077
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	RGPD4 RGPD1 SALL4 CHD7 MIDEAS KLF5 RGPD3 MGA	3.01e-08	146	114	8	23892456
Pubmed	Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4.	LILRA1 LILRB1 LILRB4	3.43e-08	3	114	3	10941837
Pubmed	Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor.	LILRB3 LILRA3 LILRB4	3.43e-08	3	114	3	9278324
Pubmed	A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.	LILRB3 LILRA3 LILRB1	1.37e-07	4	114	3	9382880
Pubmed	Plasticity in the organization and sequences of human KIR/ILT gene families.	LILRA1 LILRA3 LILRB4	1.37e-07	4	114	3	10781084
Pubmed	LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.	LILRA1 LILRA3 LILRB1	1.37e-07	4	114	3	21559424
Pubmed	HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding.	LILRA1 LILRA3 LILRB1	1.37e-07	4	114	3	21270408
Pubmed	Limited expression of nuclear pore membrane glycoprotein 210 in cell lines and tissues suggests cell-type specific nuclear pores in metazoans.	RGPD4 RGPD1 NUP214 RGPD3	1.45e-07	15	114	4	14697343
Pubmed	Interaction network of human early embryonic transcription factors.	NAB1 RGPD1 POU2F1 CHD7 NUP214 RREB1 MIDEAS ALMS1 KDM2B MGA	2.59e-07	351	114	10	38297188
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	RGPD4 RGPD1 NUP214 RGPD3 SLITRK5 MAP7D2 MGA CUX1	5.88e-07	215	114	8	35973513
Pubmed	Glatiramer Acetate Enhances Myeloid-Derived Suppressor Cell Function via Recognition of Paired Ig-like Receptor B.	LILRA1 LILRB3 LILRB1	6.81e-07	6	114	3	30068593
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	MAP7D3 DIDO1 CHD7 NUP214 RREB1 MIDEAS CDKAL1 KLF5 MACO1 RGPD3 CIZ1 KDM2B DCLRE1A SRRM2 MGA CUX1 SAMD4A	1.11e-06	1294	114	17	30804502
Pubmed	Nup358, a nucleoporin, functions as a key determinant of the nuclear pore complex structure remodeling during skeletal myogenesis.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	21205196
Pubmed	Haploinsufficiency of RanBP2 is neuroprotective against light-elicited and age-dependent degeneration of photoreceptor neurons.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	18949001
Pubmed	Selective impairment of a subset of Ran-GTP-binding domains of ran-binding protein 2 (Ranbp2) suffices to recapitulate the degeneration of the retinal pigment epithelium (RPE) triggered by Ranbp2 ablation.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	25187515
Pubmed	Interconversion of red opsin isoforms by the cyclophilin-related chaperone protein Ran-binding protein 2.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	9037092
Pubmed	Localization of the Ran-GTP binding protein RanBP2 at the cytoplasmic side of the nuclear pore complex.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	8603673
Pubmed	Complex genomic rearrangements lead to novel primate gene function.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	15710750
Pubmed	Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	26632511
Pubmed	Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	24403063
Pubmed	Distinct and atypical intrinsic and extrinsic cell death pathways between photoreceptor cell types upon specific ablation of Ranbp2 in cone photoreceptors.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	23818861
Pubmed	Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	11353387
Pubmed	Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	30944974
Pubmed	Nucleoporin Nup358 drives the differentiation of myeloid-biased multipotent progenitors by modulating HDAC3 nuclear translocation.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	38838144
Pubmed	Kinesin-1 and mitochondrial motility control by discrimination of structurally equivalent but distinct subdomains in Ran-GTP-binding domains of Ran-binding protein 2.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	23536549
Pubmed	Retina-specifically expressed novel subtypes of bovine cyclophilin.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	7559465
Pubmed	Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	17372272
Pubmed	Proteostatic Remodeling of Small Heat Shock Chaperones─Crystallins by Ran-Binding Protein 2─and the Peptidyl-Prolyl cis-trans Isomerase and Chaperone Activities of Its Cyclophilin Domain.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	38657106
Pubmed	Identification of RanBP2- and kinesin-mediated transport pathways with restricted neuronal and subcellular localization.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	12191015
Pubmed	Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	22821000
Pubmed	Neuroprotection resulting from insufficiency of RANBP2 is associated with the modulation of protein and lipid homeostasis of functionally diverse but linked pathways in response to oxidative stress.	RGPD4 RGPD1 RGPD3	1.19e-06	7	114	3	20682751
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RGPD4 RGPD1 CHD7 NUP214 RREB1 ALMS1 RGPD3 KDM2B MGA CUX1	1.27e-06	418	114	10	34709266
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	FRMPD4 ADAMTS3 DIDO1 ALMS1 MCF2L SRRM2	1.27e-06	104	114	6	9205841
Pubmed	The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2.	RGPD4 RGPD1 RGPD3	1.90e-06	8	114	3	22262462
Pubmed	The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity.	RGPD4 RGPD1 RGPD3	1.90e-06	8	114	3	21670213
Pubmed	Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes.	RGPD4 RGPD1 RGPD3	1.90e-06	8	114	3	28745977
Pubmed	Critical role of RanBP2-mediated SUMOylation of Small Heterodimer Partner in maintaining bile acid homeostasis.	RGPD4 RGPD1 RGPD3	1.90e-06	8	114	3	27412403
Pubmed	Mice lacking Ran binding protein 1 are viable and show male infertility.	RGPD4 RGPD1 RGPD3	1.90e-06	8	114	3	21310149
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MAP7D3 PDLIM7 RBM26 DIDO1 MIDEAS ALMS1 CIZ1 KDM2B DLG1 MGA CUX1	2.04e-06	549	114	11	38280479
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	MAP7D3 PDLIM7 KIAA1549 CDKAL1 ALMS1 MACO1 TMEM131 VPS13B	2.65e-06	263	114	8	34702444
Pubmed	Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	18394993
Pubmed	The docking of kinesins, KIF5B and KIF5C, to Ran-binding protein 2 (RanBP2) is mediated via a novel RanBP2 domain.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	11553612
Pubmed	The zinc finger cluster domain of RanBP2 is a specific docking site for the nuclear export factor, exportin-1.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	10601307
Pubmed	The cyclophilin-like domain mediates the association of Ran-binding protein 2 with subunits of the 19 S regulatory complex of the proteasome.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	9733766
Pubmed	Loss of Ranbp2 in motoneurons causes disruption of nucleocytoplasmic and chemokine signaling, proteostasis of hnRNPH3 and Mmp28, and development of amyotrophic lateral sclerosis-like syndromes.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	28100513
Pubmed	Impairments in age-dependent ubiquitin proteostasis and structural integrity of selective neurons by uncoupling Ran GTPase from the Ran-binding domain 3 of Ranbp2 and identification of novel mitochondrial isoforms of ubiquitin-conjugating enzyme E2I (ubc9) and Ranbp2.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	28877029
Pubmed	Association of the kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria localization and function.	RGPD4 RGPD1 RGPD3	2.84e-06	9	114	3	17887960
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	RGPD4 DLGAP1 NHSL2 RGPD1 DIDO1 SYNPO CHD7 SORBS1 KCNB1 NCAN RGPD3 DLG1 MGA CUX1	3.41e-06	963	114	14	28671696
Pubmed	Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin.	RGPD4 RGPD1 RGPD3	4.05e-06	10	114	3	8857542
Pubmed	The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes.	RGPD4 RGPD1 RGPD3	4.05e-06	10	114	3	27160050
Pubmed	Parkin ubiquitinates and promotes the degradation of RanBP2.	RGPD4 RGPD1 RGPD3	4.05e-06	10	114	3	16332688
Pubmed	Ran-dependent docking of importin-beta to RanBP2/Nup358 filaments is essential for protein import and cell viability.	RGPD4 RGPD1 RGPD3	4.05e-06	10	114	3	21859863
Pubmed	Impaired OTUD7A-dependent Ankyrin regulation mediates neuronal dysfunction in mouse and human models of the 15q13.3 microdeletion syndrome.	DLGAP1 FRMPD4 KCNB1 TULP4 SLITRK5 DLG1 SHISA6	4.15e-06	197	114	7	36604605
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	RGPD4 CACNA1B DLGAP1 FRMPD4 PCLO RGPD1 SYNPO SORBS1 UFM1 KCNB1 RGPD3 SLITRK5 MAP7D2 DLG1 SHISA6	4.92e-06	1139	114	15	36417873
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RBM26 CHD7 NUP214 RREB1 CDKAL1 ALMS1 MACO1 TTLL4 DLG1 DCLRE1A TMEM131 MGA	5.46e-06	733	114	12	34672954
Pubmed	An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age.	RGPD4 RGPD1 RGPD3	5.55e-06	11	114	3	35771867
Pubmed	RanBP2 modulates Cox11 and hexokinase I activities and haploinsufficiency of RanBP2 causes deficits in glucose metabolism.	RGPD4 RGPD1 RGPD3	5.55e-06	11	114	3	17069463
Pubmed	T-cell receptor (TCR) signaling promotes the assembly of RanBP2/RanGAP1-SUMO1/Ubc9 nuclear pore subcomplex via PKC-θ-mediated phosphorylation of RanGAP1.	RGPD4 RGPD1 RGPD3	5.55e-06	11	114	3	34110283
Pubmed	Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.	LILRA1 LILRB3 LILRB1	5.55e-06	11	114	3	24052308
Pubmed	Peering through the pore: nuclear pore complex structure, assembly, and function.	RGPD4 RGPD1 NUP214 RGPD3	7.42e-06	38	114	4	12791264
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	POU2F1 CHD7 MIDEAS KDM2B CUX1	8.20e-06	83	114	5	28794006
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	WHRN FRMPD4 SORBS1 NUP214 BTBD7 ITSN2 MCF2L SRRM2 VPS13B	8.28e-06	407	114	9	12693553
Pubmed	Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons.	RGPD4 RGPD1 RGPD3	9.58e-06	13	114	3	31427429
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SERTAD2 KIAA1549 SPIRE1 DIDO1 SYNPO LRRK1 RGP1 BAHD1 TTLL4 KDM2B	1.01e-05	529	114	10	14621295
Pubmed	Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.	LILRB3 LILRA6	1.07e-05	2	114	2	36449053
Pubmed	Gene structure, expression and chromosomal localization of murine theta class glutathione transferase mGSTT1-1.	GSTT2B GSTT2	1.07e-05	2	114	2	9854036
Pubmed	Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.	LILRB1 LILRB4	1.07e-05	2	114	2	32918786
Pubmed	Oct-1 POU and octamer DNA co-operate to recognise the Bob-1 transcription co-activator via induced folding.	POU2AF1 POU2F1	1.07e-05	2	114	2	10329190
Pubmed	Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures.	LILRA1 LILRA3	1.07e-05	2	114	2	11698424
Pubmed	Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells.	AQP12A AQP12B	1.07e-05	2	114	2	15809071
Pubmed	OBF1 enhances transcriptional potential of Oct1.	POU2AF1 POU2F1	1.07e-05	2	114	2	12727885
Pubmed	Dlg1 binds GKAP to control dynein association with microtubules, centrosome positioning, and cell polarity.	DLGAP1 DLG1	1.07e-05	2	114	2	21041448
Pubmed	Oct1 and OCA-B are selectively required for CD4 memory T cell function.	POU2AF1 POU2F1	1.07e-05	2	114	2	26481684
Pubmed	Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.	LILRB3 LILRA6	1.07e-05	2	114	2	19617579
Pubmed	Identification and characterization of GSTT3, a third murine Theta class glutathione transferase.	GSTT2B GSTT2	1.07e-05	2	114	2	12038961
Pubmed	Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.	LILRB3 LILRA6	1.07e-05	2	114	2	33526815
Pubmed	Linkage disequilibrium between two high-frequency deletion polymorphisms: implications for association studies involving the glutathione-S transferase (GST) genes.	GSTT2B GSTT2	1.07e-05	2	114	2	19424424
Pubmed	Mapping of a defined neurocan binding site to distinct domains of tenascin-C.	TNC NCAN	1.07e-05	2	114	2	9341124
Pubmed	Mammalian class theta GST and differential susceptibility to carcinogens: a review.	GSTT2B GSTT2	1.07e-05	2	114	2	11018744
Pubmed	Characterization of a cDNA and gene encoding the mouse theta class glutathione transferase mGSTT2 and its localization to chromosome 10B5-C1.	GSTT2B GSTT2	1.07e-05	2	114	2	8617493
Pubmed	Pancreas-specific aquaporin 12 null mice showed increased susceptibility to caerulein-induced acute pancreatitis.	AQP12A AQP12B	1.07e-05	2	114	2	19726746
Pubmed	The effect of LILRB1 but not LILRA3 gene polymorphism in immunopathology of ankylosing spondylitis-A parallel to KIR genes.	LILRA3 LILRB1	1.07e-05	2	114	2	30892832
Pubmed	Repetitive Exposure of IL-17 Into the Murine Air Pouch Favors the Recruitment of Inflammatory Monocytes and the Release of IL-16 and TREM-1 in the Inflammatory Fluids.	IL16 TREM1	1.07e-05	2	114	2	30555461
Pubmed	Genetic analysis of the aquaporin water channels AQP12A and AQP12B in patients with chronic pancreatitis.	AQP12A AQP12B	1.07e-05	2	114	2	36167651
Pubmed	Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma.	LILRA1 LILRA3	1.07e-05	2	114	2	20595277
Pubmed	Protocadherin 20 maintains intestinal barrier function to protect against Crohn's disease by targeting ATF6.	PCDH20 ATF6	1.07e-05	2	114	2	37407995
Pubmed	Immunoglobulin-like receptors and the generation of innate immune memory.	LILRA3 LILRA6	1.07e-05	2	114	2	35034136
Pubmed	Characterization of a human class-Theta glutathione S-transferase with activity towards 1-menaphthyl sulphate.	GSTT2B GSTT2	1.07e-05	2	114	2	1417752
Pubmed	Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.	LILRB3 LILRA6	1.07e-05	2	114	2	24096970
Pubmed	Expression of the Oct-1 transcription factor and characterization of its interactions with the Bob1 coactivator.	POU2AF1 POU2F1	1.07e-05	2	114	2	11380252
Pubmed	Plasmacytoid dendritic cells in patients with autoimmune thyroid disease.	LILRB1 LILRB4	1.07e-05	2	114	2	23666960
Pubmed	Leukocyte immunoglobulin-like receptors maintain unique antigen-presenting properties of circulating myeloid dendritic cells in HIV-1-infected elite controllers.	LILRB3 LILRB1	1.07e-05	2	114	2	20631139
Interaction	LILRA3 interactions	LILRA1 LILRA3 LILRA6 LILRB1	2.79e-07	11	111	4	int:LILRA3
Interaction	LILRA6 interactions	LILRB3 LILRA3 LILRA6	6.48e-07	4	111	3	int:LILRA6
Interaction	EN1 interactions	CHD7 MIDEAS KDM2B SRRM2 MGA TRIM37 CUX1	2.54e-06	110	111	7	int:EN1
Interaction	LILRA1 interactions	LILRA1 LILRA3	3.01e-05	2	111	2	int:LILRA1
Cytoband	19q13.4	LILRA1 LILRB3 LILRA3 LILRA6 LILRB1 LILRB4	4.92e-08	79	114	6	19q13.4
GeneFamily	CD molecules\|Inhibitory leukocyte immunoglobulin like receptors	LILRB3 LILRB1 LILRB4	6.02e-07	5	72	3	1182
GeneFamily	CD molecules\|Activating leukocyte immunoglobulin like receptors	LILRA1 LILRA3 LILRA6	1.20e-06	6	72	3	1181
GeneFamily	PDZ domain containing	WHRN SYNPO2 IL16 FRMPD4 PDLIM7 PCLO DLG1	2.41e-06	152	72	7	1220
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	LILRA1 LILRB3 LILRA3 LILRA6 LILRB1 SLC44A1 LAMP3 TREM1 IL6ST LILRB4	3.47e-06	394	72	10	471
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	CHD7 MIDEAS MSANTD1	1.23e-03	53	72	3	532
GeneFamily	Tubulin tyrosine ligase family	TTLL6 TTLL4	1.38e-03	14	72	2	779
GeneFamily	Aquaporins	AQP12A AQP12B	1.38e-03	14	72	2	305
GeneFamily	T-boxes	TBX10 MGA	2.30e-03	18	72	2	766
GeneFamily	Fibronectin type III domain containing	TRIM42 TNC CMYA5 IL6ST	3.81e-03	160	72	4	555
GeneFamily	Glutathione S-transferases	GSTT2B GSTT2	4.42e-03	25	72	2	567
GeneFamily	Ring finger proteins\|Tripartite motif containing\|ARF GTPase family	TRIM42 CMYA5 TRIM37	6.45e-03	95	72	3	59
Coexpression	HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP	LILRA1 LILRB3 LILRA3 LILRA6 LILRB1 SBNO2 LAMP3 TREM1 PLEKHO1 SAMD4A LILRB4	8.08e-07	377	114	11	M40997
Coexpression	GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP	LILRA1 PDLIM7 LILRB1 TTLL4 ERRFI1 TREM1 C3 IL6ST	2.75e-06	200	114	8	M8733
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	FRMPD4 ADAMTS3 PCLO RBM26 KIAA1549 POU2F1 SALL4 SORBS1 TULP4 MACO1 NCAN SLITRK5 KDM2B MAP7D2 MCF2L HYDIN MTUS2	5.90e-06	1106	114	17	M39071
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	DLGAP1 SLC2A9 CDKAL1 ERRFI1 DLG1 CUX1 SAMD4A	1.23e-05	176	114	7	M39223
Coexpression	TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL	LILRA1 LILRB3 PDLIM7 LILRA6 LILRB1 UFM1 SBNO2 ATF6 SLC44A1 TREM1 CUX1 IL6ST LILRB4	1.64e-05	724	114	13	M41700
Coexpression	TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING	RGPD4 RGPD1 DIDO1 RGPD3	3.67e-05	43	114	4	MM3857
Coexpression	DESCARTES_FETAL_KIDNEY_MYELOID_CELLS	LILRA1 LILRA6 LRRK1 C1orf162 LILRB1 TREM1 LILRB4	4.84e-05	218	114	7	M40221
Coexpression	DESCARTES_FETAL_INTESTINE_MYELOID_CELLS	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	6.79e-05	230	114	7	M40210
Coexpression	DESCARTES_MAIN_FETAL_MYELOID_CELLS	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1	7.01e-05	98	114	5	M40071
Coexpression	DESCARTES_FETAL_PANCREAS_MYELOID_CELLS	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	8.19e-05	237	114	7	M40264
Coexpression	GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP	WHRN IL16 DIDO1 SYNPO RREB1 RGP1	8.94e-05	166	114	6	M7722
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	LILRB3 LILRA3 SLC2A9 LILRA6 DIDO1 C1orf162 MIDEAS UFM1 TMEM131 SRRM2 CUX1	1.03e-04	634	114	11	M40866
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	CACNA1B SYNPO2 ADAMTS3 KIF26B KIAA1549 SALL4 SYNPO NUP214 PCDH20 KLF5 DENND2C DKK3 CUX1 IL6ST SAMD4A	1.01e-05	769	110	15	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	ZCCHC18 MAP7D3 ADAMTS3 TNC KIF26B PODXL POU2F1 SALL4 SYNPO CHD7 TMEM200A KLF5 NCAN SLITRK5 MAP7D2 MCF2L MTUS2	1.09e-05	976	110	17	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_200	SYNPO2 ADAMTS3 TNC KIF26B SALL4 PCDH20 CUX1	2.86e-05	169	110	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	ZCCHC18 SYNPO2 ADAMTS3 NHSL2 TNC KIF26B SPIRE1 SALL4 SYNPO CHD7 TMEM200A ALMS1 KLF5 MAP7D2 MCF2L MTUS2	4.33e-05	978	110	16	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500	MAP7D3 PODXL COBLL1 PCLO POU2F1 SALL4 CHD7 KLF5 NCAN SLITRK5 MAP7D2	5.28e-05	495	110	11	Facebase_RNAseq_e8.5_Floor Plate_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200	ADAMTS3 TNC KIF26B SALL4 PCDH20	1.11e-04	91	110	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k5
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	2.55e-08	184	114	8	ba260f8a2e6e510141a6b9c458eb0040acff0352
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 LAMP3 TREM1 LILRB4	3.41e-08	191	114	8	1e668d67bc254ea15518e2c7a029a61087609b7a
ToppCell	NS-control-d_0-4-Myeloid-Non-resident_Macrophage\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRA1 LILRB3 LILRA3 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	4.34e-08	197	114	8	496a1115071a1be6928786192de49f3adf197dfb
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRB3 MAN2A2 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	2.85e-07	170	114	7	1c3c03821c90d41de92fef3278f71093a7fd709c
ToppCell	Monocytes-IFN-activated_Monocytes\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	LILRB3 LILRA3 LILRA6 C1orf162 LILRB1 PLEKHO1 LILRB4	2.96e-07	171	114	7	df1b631618839bee4a18a2ba9c730321e5015f36
ToppCell	5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	4.51e-07	182	114	7	1fb9bdf2e9f0a9c230f109b471672f9c31e27c82
ToppCell	wk_08-11-Hematologic-Myeloid-Non-cla._mono.\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	4.86e-07	184	114	7	324f91b70913bda3509e234aaf23b46fad91e076
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 SYNPO2 TNC PDLIM7 SORBS1 C3 SAMD4A	4.86e-07	184	114	7	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	5.04e-07	185	114	7	f8de11dd53b34d36368a2082f24ec1416cb7dbae
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 LAMP3 PLEKHO1	5.22e-07	186	114	7	bec4767eaca28e41da373274704895eba75063e2
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LRRK1 C1orf162 TREM1 C3 LILRB4	5.61e-07	188	114	7	8fc15c8b78fdd1a578e34325011bc5a87a8aab31
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 LAMP3 PLEKHO1	5.61e-07	188	114	7	239bec13476dd43bebc2c6eba8d1fe35f2744673
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	5.82e-07	189	114	7	984b5f21e84dd8273d8437ac2a5a9de4e9484b9a
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PODXL MUC16 CMYA5 TMEM200A LRP5 DCLRE1A PAX9	6.46e-07	192	114	7	8899d81306770adda893b5e146df1253971754c5
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PODXL MUC16 CMYA5 TMEM200A LRP5 DCLRE1A PAX9	6.46e-07	192	114	7	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	6.46e-07	192	114	7	62eac1b8aed4fb924946b58c0237313f697a0136
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-Monocytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	6.69e-07	193	114	7	c0509798ce06da0ec725c0c7b5cc195455f2c29f
ToppCell	390C-Myeloid-Monocyte-CD14+_Monocyte\|390C / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 LILRB3 LILRA6 NUP214 LILRB1 TREM1 LILRB4	6.69e-07	193	114	7	a50ee6110ea272d9d9f41d48bb5d43711cc00a32
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 PLEKHO1 LILRB4	7.17e-07	195	114	7	3a30479857fc2805df92655c9599389559b1995d
ToppCell	control-Myeloid-Non-resident_Macrophage\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LILRA1 LILRB3 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	7.42e-07	196	114	7	646a8d47dddffdfd2d8a62245ea6cd49f9510a1a
ToppCell	Bronchial_Biopsy-Immune-Dendritic_cells\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	LILRA1 LILRB3 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	7.42e-07	196	114	7	bd828596c5b3fd5e4156f555e532f3de99d32f92
ToppCell	wk_15-18-Hematologic-Myeloid-S100A12-hi_cla._mono.\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	7.42e-07	196	114	7	aa53ae1e5d08d31cfd81b7fae46c2b5d21d4f9b2
ToppCell	AT2_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	DLGAP1 NHSL2 TNC SORBS1 NPAP1 LAMP3 C3	7.68e-07	197	114	7	fd7bdfa6bf5966ebc11fdd13915769429540ddbf
ToppCell	NS-moderate-d_07-13-Myeloid-Non-resident_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRB3 LILRA3 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	7.68e-07	197	114	7	774a5053f43ac7d614c127ae7363d32a3a194f63
ToppCell	wk_20-22-Hematologic-Myeloid-S100A12-hi_cla._mono.\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	7.68e-07	197	114	7	e862561f61a1ae1ec858b34f8d9c9a7dc8894104
ToppCell	cellseq2-Immune-Immune_Myeloid-iMON-iMON\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	7.95e-07	198	114	7	a6aa113f0af4d25c032f440c3134fe4d88ca5055
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD14\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	7.95e-07	198	114	7	4ba72ba1f0cebc93053aae72d763c33e155b6fa4
ToppCell	Mild-Myeloid-Macrophages-FCN1_high\|Mild / Condition, Lineage, Cell class and cell subclass	LILRA1 LILRB3 LILRA6 LILRB1 PLEKHO1 SAMD4A LILRB4	7.95e-07	198	114	7	17aab4dc3b2cd6eb7dda77dd51bdc20490fcfe19
ToppCell	NS-control-d_0-4-Myeloid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRA1 LILRB3 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	7.95e-07	198	114	7	846852943a8ff60f746fd49498240e25ca1c1b09
ToppCell	cellseq2-Immune-Immune_Myeloid-iMON\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	7.95e-07	198	114	7	a0ceed8689d42be6b9cde89d6c182d10b3fb14fc
ToppCell	control-Myeloid\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LILRA1 LILRB3 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	7.95e-07	198	114	7	5cfd9e600c417d7e7146a620a1871dde7163389b
ToppCell	VE-granulo2\|VE / Condition, Cell_class and T cell subcluster	LILRA1 LILRB3 LILRA6 LILRB1 TREM1 SAMD4A LILRB4	8.22e-07	199	114	7	05b47fdc01eccee0eaf4c781eeff93c47fe0533e
ToppCell	NS-control-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	PODXL COBLL1 CMYA5 PCDH20 KLF5 C3 IL6ST	8.22e-07	199	114	7	32bdfff40fd442b88489c8b0f79af3927a51a03c
ToppCell	VE-granulo2-\|VE / Condition, Cell_class and T cell subcluster	LILRA1 LILRB3 LILRA6 LILRB1 TREM1 SAMD4A LILRB4	8.22e-07	199	114	7	455e92047201ddd0c29a437a838e5fa135de7995
ToppCell	Tracheal-10x5prime-Immune_Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	8.50e-07	200	114	7	fc6aebc20ecaa67606154540a691242dc0aea867
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 CUX1 LILRB4	8.50e-07	200	114	7	83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC2A9 PCLO MUC16 KLF5 LRP5 PAX9 MCF2L	8.50e-07	200	114	7	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic-Monocyte_CD16\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LILRA1 LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	8.50e-07	200	114	7	94d7aa057a31287696a634d15ce91ce64af6455b
ToppCell	mild-CD163+_Monocytes_(Sample_ID1_d7)\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LILRA1 LILRB3 LILRB1 TREM1 PLEKHO1 SAMD4A LILRB4	8.50e-07	200	114	7	82126e25bfd8fba78dc1348fa5ad6a576289a139
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Monocytic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LILRA1 LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	8.50e-07	200	114	7	4077a85ceb8bb423c06179e16fd870ab95f8a2e8
ToppCell	droplet-Liver-Npc-21m-Myeloid-myeloid_leukocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRA6 LRRK1 C1orf162 SBNO2 TTLL4 TREM1	3.21e-06	157	114	6	264b22d0ffc43049161843bb55d2eccbf5fca575
ToppCell	droplet-Liver-Npc-21m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRA6 LRRK1 C1orf162 SBNO2 TTLL4 TREM1	3.21e-06	157	114	6	67945d37027be62c880d3072afa7ca7e97c76c20
ToppCell	droplet-Spleen-nan-21m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 NHSL2 KLF5 TREM1 C3 LILRB4	4.58e-06	167	114	6	cfcd72292c733cdb18c92fdb61b68f6806d22c8c
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-granulocyte\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 NHSL2 KLF5 TREM1 C3 LILRB4	4.74e-06	168	114	6	c0ff30e2c47005514131a0866cf10a1c228128fc
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	LILRA1 SLC2A9 LILRA6 C1orf162 PLEKHO1 LILRB4	4.90e-06	169	114	6	d4bd489ebdb86e70ed5e3dbbe8518c6cae2197e5
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 NHSL2 KLF5 TREM1 C3 LILRB4	4.90e-06	169	114	6	1000eaf5158596b4898bedcc802b31db76b05a48
ToppCell	droplet-Spleen-SPLEEN-30m-Myeloid\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LILRB3 NHSL2 KLF5 TREM1 C3 LILRB4	4.90e-06	169	114	6	83b854fa8fd9017df8f9207d9ced260eee98e8c1
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 TNC PDLIM7 SORBS1 DKK3 SAMD4A	5.07e-06	170	114	6	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 TNC PDLIM7 SORBS1 DKK3 SAMD4A	5.07e-06	170	114	6	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	(7)_MNP-(7)_DC_activated\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SYNPO2 SYNPO LRRK1 KLF5 LAMP3 KDM2B	5.07e-06	170	114	6	4ab495b38a071fa8207331df2ce0d78a2dcd034e
ToppCell	COVID-19-kidney-PEC\|kidney / Disease (COVID-19 only), tissue and cell type	DLGAP1 ADAMTS3 NHSL2 TNC KIF26B C3	5.42e-06	172	114	6	36a96714a0eb6ac438648135336c9791881ddadb
ToppCell	Bronchial_Biopsy-Immune-Luminal_Macrophages\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	LILRB3 LILRA6 C1orf162 LILRB1 TREM1 LILRB4	5.99e-06	175	114	6	1cf99de391552d4f8dbe2ed5b01fc3b8adca61b6
ToppCell	367C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CFAP91 PCLO SYNPO LRRK1 LAMP3 KDM2B	6.39e-06	177	114	6	a0ff337f11bdb11959ac71805ff94be6b4ec1083
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 SALL4 CMYA5 DENND2C DLG1 MCF2L	6.81e-06	179	114	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-kidney-Epi_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	ADAMTS3 NHSL2 TNC KIF26B C3 DKK3	6.81e-06	179	114	6	e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 C1orf162 LILRB1 TREM1 LILRB4	7.26e-06	181	114	6	bad77767e64cc093a827a6b0f3f401f3f108e457
ToppCell	Nasal_Brush-Immune-Dendritic_cells\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	LILRA1 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	7.73e-06	183	114	6	b1daec831990a53e846c089cebfcf4f8440820e4
ToppCell	(7)_DC_activated\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	SYNPO2 SYNPO LRRK1 KLF5 LAMP3 KDM2B	7.97e-06	184	114	6	b89871a3e36fde6daa68daf116f8c8d587554c0f
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNPO2 TNC KIF26B PDLIM7 SORBS1 SAMD4A	8.22e-06	185	114	6	e58a009aaf342be019a909747b1895d5987d4daf
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-cDC2\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 C1orf162 LILRB1 LAMP3 PLEKHO1	8.48e-06	186	114	6	44785bd171f424ad61437275026439fae3cb8d8c
ToppCell	wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 LILRB4	8.48e-06	186	114	6	be50f5c7f32b3126442ebff1e7d38aa78b6e4e71
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 LILRB4	8.74e-06	187	114	6	23be50d81f4404a609dea821e1a66d221c0e0615
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SYNPO2 TNC KIF26B PDLIM7 SORBS1 DKK3	9.01e-06	188	114	6	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LILRB3 C1orf162 LILRB1 LAMP3 TREM1 LILRB4	9.29e-06	189	114	6	35380ca9409206e82528bde4f3795057b015278a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 SLC2A9 KIF26B ERRFI1 HYDIN SAMD4A	9.29e-06	189	114	6	3b48b0d220cc24d5170713d61fa91f5bb6c21841
ToppCell	LA-13._Vascular_Smooth_Muscle\|World / Chamber and Cluster_Paper	SYNPO2 TNC PDLIM7 COBLL1 SORBS1 TMEM200A	9.29e-06	189	114	6	6b3e88751b95fc2173f2c3d5061ed632d0c5f01c
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SYNPO2 FRMPD4 TNC PDLIM7 SLITRK5 PLEKHO1	9.29e-06	189	114	6	63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TNC TTLL6 KLF5 C3 DKK3 SAMD4A	9.29e-06	189	114	6	319e42f6e2322208de78bc666fb2c074707eb4da
ToppCell	Mesenchymal-airway_smooth_muscle_cell\|World / Lineage, Cell type, age group and donor	SYNPO2 TNC KIF26B PDLIM7 SORBS1 DKK3	9.57e-06	190	114	6	645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCell	normal_Lymph_Node-Myeloid_cells-Activated_DCs\|normal_Lymph_Node / Location, Cell class and cell subclass	SYNPO2 SYNPO LRRK1 KLF5 LAMP3 KDM2B	9.57e-06	190	114	6	15978ddd37b521343f88b62dad1643077fc22b2b
ToppCell	wk_20-22-Hematologic-Myeloid-Neutrophil\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	9.57e-06	190	114	6	5da4a90f56f66567614d84b9b437f559006ea51c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DLGAP1 SLC2A9 KIF26B HYDIN CUX1 SAMD4A	9.86e-06	191	114	6	1cb02007adb344f17ef73d58890f91298c7cf5a1
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 C1orf162 LILRB1 LAMP3 LILRB4	9.86e-06	191	114	6	a898153490fb9e8c4331c5dce63dbfb5185bccf2
ToppCell	PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 C1orf162 TREM1 LILRB4	1.02e-05	192	114	6	aa65557b35d3eba9f24b970849255d05174d1c05
ToppCell	367C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	SYNPO2 SERTAD2 SYNPO LRRK1 LAMP3 KDM2B	1.02e-05	192	114	6	e44e37e5aeba8628556020d05e1606b28e2faa4f
ToppCell	Monocytes-Inflammatory_CD16+_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	LILRA1 LILRB3 LILRA3 C1orf162 LILRB1 CUX1	1.02e-05	192	114	6	4be5c2c946337cd3e710137726358adca563f146
ToppCell	wk_20-22-Hematologic-Myeloid-DC3\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 C1orf162 LILRB1 PLEKHO1 LILRB4	1.05e-05	193	114	6	12d1e7ed0bcd1259d6dc8ae962aad69586e5d26b
ToppCell	PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_monocyte_(14)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LILRA1 LILRB3 LILRA6 C1orf162 LILRB1 TREM1	1.05e-05	193	114	6	b044fca95f519ff2ceb378afe40a95911931a29e
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	DLGAP1 COBLL1 DIDO1 ERRFI1 LRP5 DLG1	1.05e-05	193	114	6	503a979328c68b096680b71359a26f02fafdff35
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 CFAP91 C1orf141 KCNB1 LAMP3 HYDIN	1.05e-05	193	114	6	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SYNPO2 IL16 ADAMTS3 NHSL2 C3 DKK3	1.08e-05	194	114	6	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	1.08e-05	194	114	6	e2d0dfb92356fa7ad7008aa8ac4198e2ac5d2495
ToppCell	medial-Hematologic-Nonclassical_Monocyte\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB3 NUP214 C1orf162 LILRB1 CUX1	1.08e-05	194	114	6	ac203d388a3a3884e316dec0dcbd408e43c6ef6c
ToppCell	medial-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB3 NUP214 C1orf162 LILRB1 CUX1	1.08e-05	194	114	6	202e5070728191c46161fa7d931f00be1c7559d4
ToppCell	Nasal_Brush-Immune\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	LILRA1 C1orf162 LILRB1 TREM1 PLEKHO1 LILRB4	1.08e-05	194	114	6	3135bc4a8112c5dee108e3b8e775f508b65191f1
ToppCell	medial-Hematologic-Nonclassical_Monocyte-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB3 NUP214 C1orf162 LILRB1 CUX1	1.08e-05	194	114	6	002cd317732fc6b0d9a72fb46199f71db5a638a7
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LILRA1 LILRB3 LILRA6 NUP214 C1orf162 TREM1	1.08e-05	194	114	6	b191851b2287afc8c47320f5488fd22e2a454aa6
ToppCell	(2)_Mono_macro\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	LILRA1 LILRB3 C1orf162 LILRB1 TREM1 LILRB4	1.08e-05	194	114	6	7c05525614ee8cdfcbf22cce9146a8e73af7d14e
ToppCell	distal-Hematologic-Nonclassical_Monocyte\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB3 NUP214 C1orf162 LILRB1 CUX1	1.11e-05	195	114	6	6f417bb464b8ae6a50bbab5db5a6d5760c02122f
ToppCell	distal-2-Hematologic-Nonclassical_Monocyte\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	LILRA1 LILRB3 NUP214 C1orf162 LILRB1 CUX1	1.11e-05	195	114	6	34bed73e4dae34b0f1076b7ff9dc7ea2096c1796
ToppCell	moderate-Myeloid-Monocyte-derived_Macrophage\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	LILRA3 LILRA6 LILRB1 PLEKHO1 SAMD4A LILRB4	1.11e-05	195	114	6	9c9634906168239cf978adb398787692437bf9e7
ToppCell	NS-critical-d_07-13-Myeloid-Non-resident_Macrophage\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRA1 LILRA3 C1orf162 LILRB1 PLEKHO1 LILRB4	1.11e-05	195	114	6	ee8743d39996bb756f50db32748e8a902d3294b8
ToppCell	LAM-Myeloid-Monocyte\|LAM / Condition, Lineage and Cell class	LILRA1 LILRB3 LILRA3 NUP214 C1orf162 LILRB1	1.11e-05	195	114	6	7ef400e068e730e18bbdb86f2daa7caf82602349
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LILRA1 LILRA6 LILRB1 TREM1 PLEKHO1 LILRB4	1.11e-05	195	114	6	10ce1b6961f10372d1f65388cbf3626a5fcd6840
ToppCell	15-Trachea-Immune-Hematopoietic,_Macrophage\|Trachea / Age, Tissue, Lineage and Cell class	LILRA1 LILRB3 C1orf162 LILRB1 PLEKHO1 LILRB4	1.11e-05	195	114	6	495453b3cf08fa3c5d37ad3a2bf9c526118f9600
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LILRA1 LILRB3 LILRA6 C1orf162 TREM1 LILRB4	1.11e-05	195	114	6	aa3914e277918299dc7d2995c0c72288462ad43d
ToppCell	NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	LILRA3 LILRA6 LILRB1 PLEKHO1 SAMD4A LILRB4	1.11e-05	195	114	6	d87c83d2d421c9291d0a10bc9db850e9fb337667
ToppCell	390C-Myeloid-Monocyte\|390C / Donor, Lineage, Cell class and subclass (all cells)	LILRA1 LILRB3 LILRA6 NUP214 TREM1 LILRB4	1.11e-05	195	114	6	6f09bfd6394c10c90c23d130a18941bf490e1a8f
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B DLGAP1 FRMPD4 PCLO KCNB1 MTUS2	1.14e-05	196	114	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-neutrophil\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	LILRB3 LILRA6 NUP214 C1orf162 LILRB1 TREM1	1.14e-05	196	114	6	ad193b231ff2f7c72590fab79919c179d5d2f327
Computational	Neighborhood of HCK	LILRA1 LILRB3 LILRA3 LILRA6 LILRB1 TREM1	3.18e-05	94	70	6	GNF2_HCK
Computational	Neighborhood of TNFRSF1B	LILRA1 LILRB3 LILRA3 LILRA6 LILRB1	6.18e-05	65	70	5	GNF2_TNFRSF1B
Computational	Neighborhood of CD1D	LILRA1 LILRB3 LILRA3 LILRA6	2.01e-04	45	70	4	GNF2_CD1D
Computational	Neighborhood of CD33	LILRA1 LILRB3 LILRA3 LILRA6	3.53e-04	52	70	4	GNF2_CD33
Drug	Cefotetan [69712-56-7]; Up 200; 7uM; PC3; HT_HG-U133A	IL16 NAB1 LILRB1 CDKAL1 C3 MCF2L DKK3 IL6ST SAMD4A	6.49e-07	198	113	9	3997_UP
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; MCF7; HT_HG-U133A	PODXL PDLIM7 COBLL1 SBNO2 ALMS1 BTBD7 PLEKHO1 SAMD4A	5.11e-06	191	113	8	7438_DN
Drug	Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A	MAN2A2 PDLIM7 DIDO1 ALMS1 CIZ1 VPS13B IL6ST SAMD4A	5.52e-06	193	113	8	3474_UP
Drug	Flucloxacillin sodium [1847-24-1]; Up 200; 8.4uM; HL60; HT_HG-U133A	CNMD COBLL1 PCLO SBNO2 ATF6 BTBD7 LRP5 SAMD4A	6.66e-06	198	113	8	3128_UP
Drug	1-iodobutane	C3 TRIM37	2.44e-05	2	113	2	CID000010962
Drug	11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A	WHRN TNC SBNO2 KLF5 PLD2 PLEKHO1 SAMD4A	4.78e-05	191	113	7	7538_UP
Drug	Chlorzoxazone [95-25-0]; Up 200; 23.6uM; PC3; HT_HG-U133A	SLC2A9 TNC PDLIM7 LRRK1 SBNO2 BTBD7 PAX9	5.28e-05	194	113	7	2100_UP
Drug	Guanethidine sulfate [60-02-6]; Up 200; 13.4uM; MCF7; HT_HG-U133A	CNMD SYNPO SORBS1 NUP214 TREM1 DLG1 SAMD4A	5.63e-05	196	113	7	3171_UP
Drug	Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; PC3; HT_HG-U133A	MAN2A2 SLC2A9 MAP7D3 KCNB1 TTLL4 TREM1 MCF2L	5.63e-05	196	113	7	4479_UP
Drug	Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A	WHRN PDLIM7 CHD7 LRRK1 SLC44A1 BTBD7 PLEKHO1	5.63e-05	196	113	7	4296_DN
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A	MAP7D3 PDLIM7 COBLL1 NAB1 LRRK1 BTBD7 C3	5.81e-05	197	113	7	3798_DN
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A	MAN2A2 PDLIM7 SERTAD2 DIDO1 BAHD1 BTBD7 PLEKHO1	5.81e-05	197	113	7	4963_DN
Drug	Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A	SLC2A9 PCLO SORBS1 NUP214 KCNB1 BTBD7 CIZ1	6.00e-05	198	113	7	4139_DN
Drug	Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A	PODXL COBLL1 PCLO RBM26 CIZ1 PLEKHO1 VPS13B	6.00e-05	198	113	7	5393_UP
Drug	Thiethylperazine malate [52239-63-1]; Up 200; 6uM; HL60; HT_HG-U133A	IL16 PCLO RBM26 KCNB1 PLD2 SAMD4A LILRB4	6.00e-05	198	113	7	6154_UP
Drug	Spiperone [749-02-0]; Down 200; 10.2uM; HL60; HG-U133A	MAN2A2 NUP214 BAHD1 ATF6 ITSN2 CIZ1 DLG1	6.20e-05	199	113	7	1559_DN
Drug	Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A	WHRN SORBS1 NUP214 ATF6 SLC44A1 C3 IL6ST	6.20e-05	199	113	7	2289_DN
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A	CACNA1B IL16 FRMPD4 LILRB1 SLC44A1 SYCP1 TBX10	6.20e-05	199	113	7	3754_UP
Drug	Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; PC3; HT_HG-U133A	MAN2A2 SLC2A9 SBNO2 KCNB1 C3 MCF2L PLEKHO1	6.39e-05	200	113	7	5784_UP
Drug	Aztreonam [78110-38-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A	WHRN IL16 MAN2A2 SLC2A9 RBM26 BTBD7 SYCP1	6.39e-05	200	113	7	5535_UP
Drug	Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A	SYNPO SORBS1 LRRK1 TTLL4 LAMP3 C3 PAX9	6.39e-05	200	113	7	3619_UP
Drug	methylthymol blue	NUP214 TRIM37	7.30e-05	3	113	2	CID000073037
Drug	alpha-bromo-4-chlorophenylacetic acid	LILRB3 LILRA6	7.30e-05	3	113	2	CID010490868
Drug	l-945	LILRB3 LILRA6	7.30e-05	3	113	2	CID000097919
Disease	Schizophrenia	CACNA1B DLGAP1 ADAMTS3 CMYA5 LILRB1 SBNO2 GSTT2 KCNB1 KLF5 NCAN TREM1 KDM2B DLG1 DKK3	4.30e-06	883	108	14	C0036341
Disease	Charcot-Marie-Tooth disease (biomarker_via_orthology)	GSTT2B GSTT2	1.33e-05	2	108	2	DOID:10595 (biomarker_via_orthology)
Disease	leukocyte immunoglobulin-like receptor subfamily B member 1 measurement	LILRA1 LILRB1 LILRB4	2.10e-05	15	108	3	EFO_0008208
Disease	non-high density lipoprotein cholesterol measurement	ADAMTS3 PSG3 COBLL1 SERTAD2 CHD7 MIDEAS CDKAL1 MACO1 NCAN ITSN2 HYDIN	6.26e-05	713	108	11	EFO_0005689
Disease	leukocyte immunoglobulin-like receptor subfamily B member 3 measurement	LILRB3 LILRA6	1.97e-04	6	108	2	EFO_0802705
Disease	leukocyte immunoglobulin-like receptor subfamily A member 6 measurement	LILRB3 LILRA6	1.97e-04	6	108	2	EFO_0801767
Disease	systemic scleroderma	NAB1 CHD7 ATF6 TULP4	2.74e-04	85	108	4	EFO_0000717
Disease	Developmental regression	CACNA1B NUP214	2.75e-04	7	108	2	C1836830
Disease	HWESASXX measurement	CNMD RREB1	2.75e-04	7	108	2	EFO_0021147
Disease	bipolar disorder	WHRN PODXL PCLO CDKAL1 KCNB1 NCAN LAMP3 TMEM131 PLEKHO1	2.76e-04	577	108	9	MONDO_0004985
Disease	glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement	RGPD1 RGP1	3.66e-04	8	108	2	EFO_0800533
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	CHD7 SLC44A1	4.70e-04	9	108	2	EFO_0800517
Disease	Hypermetropia	CHD7 ALMS1 TULP4 SHISA6	5.68e-04	103	108	4	HP_0000540
Disease	vital capacity	SLC2A9 ADAMTS3 PODXL PCLO C16orf96 CHD7 RREB1 TULP4 ERRFI1 SYCP1 DLG1 DKK3 SAMD4A	5.90e-04	1236	108	13	EFO_0004312
Disease	interleukin 13 measurement	LILRA1 LILRB1 HACE1	6.05e-04	45	108	3	EFO_0008171
Disease	cognitive function measurement	SYNPO2 FRMPD4 PDLIM7 CNMD CHD7 MSANTD1 ALMS1 KCNB1 TULP4 ITSN2 TREM1 TMEM131 TRIM37 HYDIN	7.49e-04	1434	108	14	EFO_0008354
Disease	testosterone measurement	DLGAP1 ADAMTS3 NHSL2 COBLL1 NAB1 SERTAD2 C16orf96 CHD7 RREB1 MIDEAS GSTT2B MACO1 LRP5	7.86e-04	1275	108	13	EFO_0004908
Disease	3-formylindole measurement	GSTT2B GSTT2	1.01e-03	13	108	2	EFO_0801025
Disease	non-dense area measurement, mammographic density measurement	RGPD1 RGP1	1.35e-03	15	108	2	EFO_0005941, EFO_0006504
Disease	response to peritoneal dialysis, peritoneal solute transfer rate	SERTAD2 KDM2B	1.35e-03	15	108	2	EFO_0600089, EFO_0600090
Disease	reticulocyte measurement	COBLL1 NAB1 SERTAD2 RREB1 MIDEAS CDKAL1 SBNO2 MACO1 LRP5 TMEM131 CUX1	1.67e-03	1053	108	11	EFO_0010700
Disease	oral motor function measurement	DLGAP1 ADAMTS3	1.74e-03	17	108	2	EFO_0021793
Disease	Malignant neoplasm of breast	PDLIM7 POU2F1 SORBS1 NUP214 PCDH20 ITSN2 TREM1 MAP7D2 PLD2 VPS13B CUX1	1.95e-03	1074	108	11	C0006142
Disease	borna disease (biomarker_via_orthology)	IL16 ATF6	1.95e-03	18	108	2	DOID:5154 (biomarker_via_orthology)
Disease	diabetes mellitus	COBLL1 RREB1 CDKAL1	2.01e-03	68	108	3	EFO_0000400
Disease	polymyositis	NAB1 LRP5	2.42e-03	20	108	2	EFO_0003063
Disease	free androgen index	COBLL1 SERTAD2 CHD7 RREB1 LRP5 CUX1	2.58e-03	374	108	6	EFO_0007005
Disease	Immunologic Deficiency Syndromes	CHD7 C3	3.19e-03	23	108	2	C0021051

Protein segments in the cluster

Peptide	Gene	Start	Entry
PTTTKALCPLYTSPR	TREM1	156	Q9NP99
YTSPRTVTQAPPKST	TREM1	166	Q9NP99
LPKIYSHPPTESSKT	CABS1	6	Q96KC9
PTSIPTSSALPVKCY	C1orf141	356	Q5JVX7
SPPAYSGPAVALLVT	AQP12A	171	Q8IXF9
SYPPLAISLKKPSAA	CUX1	756	P39880
PASPARYSPVSKAVL	DLG1	441	Q12959
IPTLPSTFYSHTEKP	ALMS1	1421	Q8TCU4
VTIPPKSSLSVPYVI	C3	886	P01024
VSSCITTYKKTPPPV	DLGAP1	531	O14490
IKAEPQPLSPASSSY	ATF6	86	P18850
SPPAYSGPAVALLVT	AQP12B	171	A6NM10
TPRPSITYKTANSSP	CACNA1B	2196	Q00975
IPGYTPTTVDSPLQK	CHD7	2346	Q9P2D1
ISKPYISNTLPSDAP	COBLL1	276	Q53SF7
YTFPPTSTKHLSIPS	CFAP91	171	Q7Z4T9
PIKLSPTSPVYRGSS	MTUS2	1341	Q5JR59
YPVPTLSSTITVIAP	RBM26	246	Q5T8P6
TASLIQPLPIPYSSS	ITSN2	171	Q9NZM3
ATVDTPTLATAKPPY	KIAA1549	931	Q9HCM3
SVVKPGSYTPLTFPS	MUC16	1271	Q8WXI7
SYPSSLTPFLVTTIP	MUC16	4451	Q8WXI7
TEASLSPPAKSTPLY	MSANTD1	156	Q6ZTZ1
YLLVLPSTLPGSPVT	PCDH20	751	Q8N6Y1
ASTTHRYPKTPSPTV	PODXL	321	O00592
SYPSPITAAAAKVPT	PAX9	161	P55771
PVISKTATKAYPQSP	MAP7D2	291	Q96T17
STSYSLKPHSVPPVS	MGA	881	Q8IWI9
TKSSYKSILPYPVSP	MGA	911	Q8IWI9
YSKPTLSALPSPLVT	LILRB4	121	Q8NHJ6
IEASPLPSSYPGKTA	LRRK1	241	Q38SD2
LTSLPVSSIPIYKLP	NAB1	86	Q13506
VSSIPIYKLPEGSPT	NAB1	91	Q13506
PAAAHLLPSPYSKIT	KIF26B	1841	Q2KJY2
SSSTKATLYPPILNP	LRP5	1486	O75197
SPLSPVSPHYSSKFV	MACO1	631	Q8N5G2
LVTSADYKLPSPTSP	PCLO	2546	Q9Y6V0
AAVPYTPNLLPTSST	HACE1	861	Q8IYU2
LESPSAPISTAKPNY	IL16	336	Q14005
SSVPYSTAKTPHPVL	NUP214	1141	P35658
TEVTVGPSLAPYSLP	LAMP3	121	Q9UQV4
YNKPTLSALPSPVVA	LILRA6	121	Q6PI73
YSKPTLSALPSPVVA	LILRB3	121	O75022
AKKTLPTPSPEAYQA	GSTT2B	221	P0CG30
PPRYTFAPSVSLNKT	PDLIM7	101	Q9NR12
KAIFPSPTSLVATTP	POU2F1	451	P14859
PSSVLTYASPPLITN	POU2AF1	136	Q16633
IKHSTPSPTKYSLSP	RGPD3	776	A6NKT7
SKRSSTLPPPYLLEA	ADAMTS3	1051	O15072
TIPSLSKPSVYHEPS	FAM126A	126	Q9BYI3
FVTLPKKPYSAPVSQ	HYDIN	1216	Q4G0P3
SPESIKAYLKQAPPS	IL6ST	506	P40189
PESSIYTTASAKTPP	KCNB1	721	Q14721
LAVDYPKTPTGSPAT	KDM2B	486	Q8NHM5
LAAVKAPSPPSQSLY	C16orf96	1041	A6NNT2
PVSDAKVYTPSISKP	CDKAL1	491	Q5VV42
VIQPYPSPKSAFISA	FRMPD4	151	Q14CM0
ETKSSETPPYLLSPV	CMYA5	2801	Q8N3K9
AKKTLPTPSPEAYQA	GSTT2	221	P0CG29
PEKTAAPSPSLLYKS	DIDO1	516	Q9BTC0
SILAKPSSSPDPRYL	DIDO1	1011	Q9BTC0
PSRKTALVPPSADYS	BAHD1	731	Q8TBE0
VPFYITASLISPSPL	CRYM-AS1	66	A6NIL9
APFPAPGRTITVKSY	DENND2C	631	Q68D51
YLPSVKAAPPDCTST	BTBD7	816	Q9P203
QPTSLTLLYPLASPS	MAN2A2	1116	P49641
LPLISKQSPQTSFPY	MAP7D3	526	Q8IWC1
SLEGYVSSAPLTKPP	MCF2L	996	O15068
IPTKAGTFIAPPVYS	MIDEAS	611	Q6PJG2
AGIPPAKIPYVTLST	SLC2A9	346	Q9NRM0
TAIPAVPTITTYPVK	KRTAP29-1	11	A8MX34
PSEYTTSPKSSVLCP	SLC44A1	146	Q8WWI5
LSSTPAPKYLKILPS	DCLRE1A	526	Q6PJP8
PSINTSLLTPPYLKF	CCDC168	5071	Q8NDH2
PPAKLSSIPGESLTY	C1orf162	106	Q8NEQ5
SVVYLKTETALPPTP	SALL4	151	Q9UJQ4
TKYLSSSPSNPKTVP	CFAP47	1161	Q6ZTR5
TATSAPVKPGPALSY	DKK3	26	Q9UBP4
TIPSLSKPSIYHEPS	FAM126B	126	Q8IXS8
AYSKPTLSALPSPVV	LILRA3	121	Q8N6C8
TPKPSISSSNLYPRE	PSG3	146	Q16557
IKHSTPSPTKYSLSP	RGPD1	766	P0DJD0
PKLQPVHSPSSSLSY	GAREM2	511	Q75VX8
IKHSTPSPTKYSLSP	RGPD4	776	Q7Z3J3
PPASLLQPTASYSRK	TRIM37	641	O94972
KVRSSGDSLPSPYPV	TRIM42	496	Q8IWZ5
EPPKPYSLVRESSSS	SRRM2	166	Q9UQ35
SVSVFGLYPPPSKTT	TMEM200A	251	Q86VY9
AYIKPTLSALPSPVV	LILRA1	121	O75019
AYIKPTLSAQPSPVV	LILRB1	121	Q8NHL6
KKPSVLYLPLTSPTA	NHSL2	1006	Q5HYW2
PIKVLPTSPTLASYA	RGP1	366	Q92546
APPTYTETLSTAPLA	SYNPO	561	Q8N3V7
TAPPSPAAETKVYSL	NCAN	666	O14594
LPPSYESAVKTNPSK	SHISA6	296	Q6ZSJ9
LSSVPPPDITYTLAL	SBNO2	226	Q9Y2G9
YASVSPANPSSKRPL	WHRN	651	Q9P202
LPLTTYTSQVSAPLP	NPAP1	411	Q9NZP6
ATYTPQAPKKLTPTE	PLEKHO1	251	Q53GL0
RTPSPKSLPSYLNGV	ERRFI1	331	Q9UJM3
KYILSIIPSSGPTTP	PVALEF	81	A0A1B0GWK0
CSPPAYATLTVKPSS	CNMD	21	O75829
YKAAKNPSPTTRPVS	CIZ1	831	Q9ULV3
ILAPSETYPLPTTSS	TBX10	11	O75333
SYLSTAFIPTIKPPI	TULP4	406	Q9NRJ4
TVVSSIKIAQPSYPP	SYNPO2	801	Q9UMS6
PSYPLAALKSQPSAA	SYNPO2	931	Q9UMS6
VATSSSAVYKPPLKP	SLITRK5	316	O94991
VPIYSSALVSSPPLV	RREB1	1016	Q92766
KTLAPYSSQPVTPSQ	SERTAD2	281	Q14140
TLSTPLPKAYTVKTP	SYCP1	846	Q15431
KPYSTLPIFSLGPSA	SPIRE1	631	Q08AE8
KPSSAYPSTTIVNPT	SORBS1	296	Q9BX66
SPLALPSPHKTYSLA	SORBS1	1051	Q9BX66
IPTDVKPSSLELPYT	TMEM131	1476	Q92545
SIPVSARVATYLPAP	TNC	701	P24821
PKSPPTLAVTASSEY	TTLL6	651	Q8N841
LPYKVLSVPESTPFT	UFM1	16	P61960
LVVSLYPSLTPTGAP	ZCCHC18	281	P0CG32
PVPVIPSFSTALYGK	VPS13B	756	Q7Z7G8
ISGKIPSPLSSSYKP	TTLL4	201	Q14679
PTYPYLLPKSTSTAN	PLD2	576	O14939
ILTPIKAYSSPSTTP	SAMD4A	411	Q9UPU9
NLTPPPSYAATIASK	KLF5	321	Q13887